130 related articles for article (PubMed ID: 6211296)
1. Platelet function in coronary artery disease: effects of coronary surgery and sulfinpyrazone.
Cade JF; Doyle DJ; Chesterman CN; Morgan FJ; Rennie GC
Circulation; 1982 Jul; 66(1):29-32. PubMed ID: 6211296
[TBL] [Abstract][Full Text] [Related]
2. Platelet tests and antiplatelet drugs in coronary artery disease.
de Boer AC; Han P; Turpie AG; Butt R; Gent M; Genton E
Circulation; 1983 Mar; 67(3):500-4. PubMed ID: 6217921
[TBL] [Abstract][Full Text] [Related]
3. Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
Al-Mondhiry H; Pierce WS; Pennock JL
J Lab Clin Med; 1985 Mar; 105(3):397-402. PubMed ID: 2579177
[TBL] [Abstract][Full Text] [Related]
4. In vivo platelet hyperactivity and factor VIII related antigen increase long after myocardial infarction. A controlled effect of sulfinpyrazone.
Cortellaro M; Boschetti C; Beggi P; Polli EE
Scand J Haematol; 1981 Feb; 26(2):106-14. PubMed ID: 6454960
[TBL] [Abstract][Full Text] [Related]
5. Platelet activation in angina at rest. Evidence by paired measurement of plasma beta-thromboglobulin and platelet factor 4.
De Caterina R; Gazzetti P; Mazzone A; Marzilli M; L'Abbate A
Eur Heart J; 1988 Aug; 9(8):913-22. PubMed ID: 2972544
[TBL] [Abstract][Full Text] [Related]
6. Studies of platelet factor 4 and beta thromboglobulin release during exercise: lack of relationship to myocardial ischemia.
Stratton JR; Malpass TW; Ritchie JL; Pfeifer MA; Harker LA
Circulation; 1982 Jul; 66(1):33-43. PubMed ID: 6177442
[No Abstract] [Full Text] [Related]
7. Platelets and antiplatelet therapy in ischemic heart disease.
Frishman WH; Miller KP
Curr Probl Cardiol; 1986 Feb; 11(2):69-136. PubMed ID: 2936576
[No Abstract] [Full Text] [Related]
8. The effect of sulfinpyrazone on treadmill exercise-induced angina pectoris.
Lewis HD; Davis JW; Hassanein KM
Cardiology; 1993; 83(4):228-33. PubMed ID: 8281538
[TBL] [Abstract][Full Text] [Related]
9. A critical appraisal of the clinical efficiency of anti-platelet drugs.
Lecompte T; Samama M
Agents Actions Suppl; 1986; 20():203-14. PubMed ID: 3544741
[No Abstract] [Full Text] [Related]
10. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
Cairns JA
Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983
[No Abstract] [Full Text] [Related]
11. Platelet activation during exercise-induced myocardial ischemia.
Green LH; Seroppian E; Handin RI
N Engl J Med; 1980 Jan; 302(4):193-7. PubMed ID: 7350460
[TBL] [Abstract][Full Text] [Related]
12. Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: direct evidence for enhanced platelet reactivity in vivo.
Smitherman TC; Milam M; Woo J; Willerson JT; Frenkel EP
Am J Cardiol; 1981 Sep; 48(3):395-402. PubMed ID: 6168192
[No Abstract] [Full Text] [Related]
13. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Sherry S
Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
[No Abstract] [Full Text] [Related]
14. Sulfinpyrazone decreases epinephrine-induced platelet aggregation after myocardial infarction.
Latour JG; Theroux P; Bourassa MG
Am J Cardiol; 1982 Nov; 50(5):938-44. PubMed ID: 6753559
[TBL] [Abstract][Full Text] [Related]
15. Relationship of plasma anti-heparin activity and platelet survival time in coronary disease.
Steele P; Rainwater J
Am Heart J; 1980 Apr; 99(4):438-42. PubMed ID: 7361647
[No Abstract] [Full Text] [Related]
16. [Controversy on platelet-inhibiting drugs].
Oelz O
Schweiz Med Wochenschr; 1985 May; 115(20):703-7. PubMed ID: 3892659
[TBL] [Abstract][Full Text] [Related]
17. Effects of the platelet inhibitor ticlopidine on exercise tolerance in stable angina pectoris.
Berglund U; Lassvik C; Wallentin L
Eur Heart J; 1987 Jan; 8(1):25-30. PubMed ID: 2949974
[TBL] [Abstract][Full Text] [Related]
18. [Platelet-specific proteins in arteriosclerosis and coronary disease].
Musiał J
Kardiol Pol; 1980; 23(8):707-13. PubMed ID: 6158591
[No Abstract] [Full Text] [Related]
19. Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease.
Steele P; Battock D; Genton E
Circulation; 1975 Sep; 52(3):473-6. PubMed ID: 1157247
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation in clinical coronary artery disease and spasm.
Rubenstein MD; Wall RT; Baim DS; Harrison DC
Am Heart J; 1981 Sep; 102(3 Pt 1):363-7. PubMed ID: 6455912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
